This study investigated whether Angiotensin-(1-7) can mitigate inflammation in lipopolysaccharide (LPS)-induced macrophages and septic mice by regulating the Warburg effect, a metabolic process where cancer cells rely on glycolysis rather than oxidative phosphorylation. The study used techniques like western blot, ELISA, qRT-PCR, and immunofluorescence staining to examine levels of inflammatory cytokines and proteins involved in the Warburg effect. Preliminary results found that Angiotensin-(1-7) reduced inflammation and modulated the Warburg effect. The conclusions were that Angiotensin-(1-7) shows promise in mitigating sepsis-related inflammation by targeting cellular metabolic pathways like the Warburg effect.